CVS Health proposes to buy Aetna for $66B: 4 things to know

Pharmacy giant CVS Health is in talks to purchase Aetna, sources familiar with the matter told The Wall Street Journal.

Advertisement

Here are four things to know.

1. CVS Health made an offer to buy Aetna for more than $200 per share, or about $66 billion.

2. Negotiations began recently and took place between CVS Health CEO Larry Merlo and Aetna CEO Mark Bertolini, Reuters reports. The deal is not expected for a few weeks, however publication of the discussion could expedite the process, the sources said. Both companies declined Reuters request for comment.

3. Aetna’s shares spiked more than 12 percent following The Wall Street Journal‘s report. The insurer’s stocks climbed as high as $180.70 per share, up from $160.65 per share, as of 3:20 p.m. CT Thursday. CVS Health’s shares dipped roughly 3 percent.

4. The deal follows Aetna’s failed merger with Humana in February, under which Aetna was required to pay Humana a $1 billion breakup fee.

This article was updated Oct. 27 at 8:22 a.m. CT.

More articles on payer issues:
Anthem to pick up another Florida Medicare Advantage plan
U of Virginia Health System, Aetna launch co-branded Medicare Advantage plan
Anthem grows net income 21% in Q3

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.